Iovance Biotherapeutics, Inc. Share Price Today: Live Updates & Key Insights
Iovance Biotherapeutics, Inc. share price today is $3.74, up -4.65%. The stock opened at $3.83 against the previous close of $3.87, with an intraday high of $3.95 and low of $3.61.
Iovance Biotherapeutics, Inc. Share Price Chart
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. Share Price Performance
Iovance Biotherapeutics, Inc. Institutional Holdings
Iovance Biotherapeutics, Inc. Market Status
Iovance Biotherapeutics, Inc. Fundamentals
Market Cap 1520.14 M
PB Ratio 2.1819
PE Ratio 0.0
Enterprise Value 1276.72 M
Total Assets 913.17 M
Volume 23502040
Iovance Biotherapeutics, Inc. Company Financials
About Iovance Biotherapeutics, Inc. & investment objective
Company Information Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally. The company offers Amtagvi, an individualized T cell therapy for solid tumor cancer and for the treatment of adult patients with previously treated advanced, or unresectable or metastatic melanomal; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It also develops lifileucel for the treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma (HNSCC); LN-145-S1 to treat melanoma and HNSCC; LN-145 Gen 3 and core biopsy for the treatment of NSCLC; LN-145 Gen 3 to treat melanoma and HNSCC; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001 for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with National Institutes of Health; the National Cancer Institute; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Organisation Biotechnology
Employees 975
Industry Biotechnology
CEO Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Iovance Biotherapeutics, Inc. FAQs
What is the share price of Iovance Biotherapeutics, Inc. today?
The current share price of Iovance Biotherapeutics, Inc. is $3.74.
Can I buy Iovance Biotherapeutics, Inc. shares in India?
Yes, Indian investors can buy Iovance Biotherapeutics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Iovance Biotherapeutics, Inc. shares in India?
You can easily invest in Iovance Biotherapeutics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Iovance Biotherapeutics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Iovance Biotherapeutics, Inc..
Can I buy fractional shares of Iovance Biotherapeutics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. has a market cap of $1520.14 M.
In which sector does Iovance Biotherapeutics, Inc. belong?
Iovance Biotherapeutics, Inc. operates in the Biotechnology sector.
What documents are required to invest in Iovance Biotherapeutics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Iovance Biotherapeutics, Inc.?
The PE ratio of Iovance Biotherapeutics, Inc. is N/A and the PB ratio is 2.18.